Gentian Diagnostics ASA · LS:A2DLP7

Gentian Diagnostics ASA financial statements

Gentian Diagnostics ASA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in NOK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue176.5M152.1M135.2M101.6M83.1M68.4M48.0M46.1M35.0M30.9M
Cost of revenue78.3M69.3M70.9M52.6M43.2M32.6M25.4M6.59M5.79M7.02M
Gross profit98.2M82.8M64.2M49.0M39.9M35.8M22.5M39.5M29.2M23.9M
Research and development23.2M21.9M36.1M24.7M26.8M26.1M19.2M3.80M3.94M2.15M
Selling, general and administrative54.3M21.7M25.1M46.6M38.4M56.2M49.2M18.2M5.96M16.3M
Operating income25.5M15.7M-12.8M-23.2M-22.8M-17.8M-27.2M-20.7M-16.2M-10.1M
Depreciation and amortization9.12M8.96M9.57M10.2M7.35M6.63M6.13M3.90M3.02M2.30M
EBITDA34.6M24.7M-3.20M-13.0M-15.5M-11.2M-21.0M-16.8M-13.2M-7.75M
Interest expense5.22M2.52M3.41M4.21M4.03M550.0K363.0K64.4K19.8K1.34M
Income before tax25.7M20.1M-10.4M-23.6M-24.8M-17.5M-39.8M-19.7M-15.1M-8.93M
Income tax12.4M-25.2M282.0K00-355.0K63.0K63.7K32.9K1.13M
Net income13.3M45.3M45.3M45.3M-24.8M-17.1M-39.9M-19.8M-15.2M-8.93M
Earnings per share, basic86.00294.00-0.69-1.53-1.61-1.11-2.59-1.29-1.08-0.80
Earnings per share, diluted86.00287.00-0.69-1.53-1.61

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents105.9M84.7M87.6M81.6M114.9M157.6M171.2M198.3M145.3M74.3M
Receivables24.3M31.3M17.0M19.2M22.6M15.2M15.5M13.9M12.1M8.25M
Inventory54.1M45.9M37.1M38.5M29.8M20.9M18.2M13.1M11.1M7.55M
Current assets184.3M162.0M141.7M139.3M167.3M193.8M205.0M225.3M170.1M91.8M
Property, plant and equipment4.42M6.26M7.75M9.25M3.36M25.6M7.78M4.74M5.10M4.74M
Goodwill0005.04M5.04M
Total assets258.5M229.7M181.0M187.8M211.8M235.3M227.2M258.0M205.2M123.0M
Accounts payable2.45M6.55M3.71M4.44M4.97M5.81M4.61M3.30M3.55M3.52M
Current liabilities34.1M30.1M25.3M22.0M22.6M22.6M17.0M11.4M8.29M7.42M
Long-term debt0
Total debt10.0M13.0M15.3M22.7M22.3M6.61M698.0K466.2K
Total liabilities53.6M35.6M34.4M33.6M37.0M40.7M18.9M12.1M8.75M7.42M
Shareholders' equity205.0M194.1M146.6M154.2M174.8M194.6M208.2M245.9M196.5M115.5M
Shares outstanding15.4M15.8M15.4M15.4M15.4M15.4M15.4M15.4M14.0M11.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations42.6M13.5M15.5M-14.0M-27.1M-7.66M-21.5M-10.9M-18.6M-7.90M
Capital spending-1.21M-1.38M-955.0K-8.64M-1.02M-6.47M-4.04M-6.15M-6.91M-7.11M
Free cash flow41.4M12.1M14.5M-22.6M-28.1M-14.1M-25.5M-17.0M-25.5M-15.0M
Cash from investing-10.8M-10.9M-4.88M-14.7M-12.8M-4.57M-4.04M-6.15M-6.91M-4.48M
Cash from financing-11.1M-4.95M-4.60M-4.33M-3.12M-1.51M-1.58M68.8M96.5M20.4M
Dividends paid-6.17M0
Share buybacks0570.0K462.0K259.0K68.5M96.1M20.4M
Change in cash20.7M-2.44M5.98M-32.9M-43.0M-13.6M-27.1M51.7M71.0M8.02M